Evolent Health, Inc.
Financials
Valuation Metrics
Evolent Health, Inc.'s Market Cap is $416M. At end of 2025 it was $457M. Ranked #2861 of 3,121 in US market (top 92%), #1592 of 1,658 on NYSE (top 96%), #176 of 205 in Health Care Equipment & Services (top 86%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $416M | US#2,861/3,121 Sec#176/205 |
| Revenue | $2.10B | US#1,407/3,121 Sec#90/205 |
| Net Income | $-505M | US—/3,121 Sec—/205 |
| Total Assets | $1.97B | US#2,099/3,121 Sec#107/205 |
| Net Assets | $383M | US#2,401/3,121 Sec#130/205 |
| Employees | 4,200 | US#1,319/3,121 Sec#94/205 |
| Value | ||
| P/B | 1.08x | US#461/3,121 Sec#23/205 |
| P/S | 0.20x | US#91/3,121 Sec#7/205 |
| FCF Yield | 4.08% | US#1,610/3,121 Sec#86/205 |
| Profitability | ||
| ROE | -131.77% | US#2,819/3,121 Sec#185/205 |
| ROA | -25.61% | US#2,857/3,121 Sec#184/205 |
| Op. Margin | -1.37% | US#2,396/3,121 Sec#137/205 |
| Revenue Growth | -4.50% | US#2,467/3,121 Sec#183/205 |
| Financial Health | ||
| Debt Ratio | 414.56% | US#2,294/3,121 Sec#178/205 |
| Total Debt | $970M | US#1,552/3,121 Sec#84/205 |
| FCF | $17M | US#2,199/3,121 Sec#135/205 |
| Cash | $116M | US#2,132/3,121 Sec#130/205 |
| Current Ratio | 1.24x | US#1,956/3,121 Sec#167/205 |
| Dividend | ||
| Div. Yield | 1.04% | US#1,303/3,121 Sec#28/205 |
| Performance | ||
| 1Y Return | -57.72% | US#2,989/3,121 Sec#195/205 |
| 1M Return | -19.32% | US#2,968/3,121 Sec#198/205 |
| From 52W High | -61.63% | US#2,929/3,121 Sec#192/205 |
| 1Y MDD | -77.42% | US#3,043/3,121 Sec#195/205 |
| Trading | ||
| Volume | 1,069,622 shares | US#1,023/3,121 Sec#60/205 |
| Trading Value | $4M | US#2,606/3,121 Sec#169/205 |
| Per Share | ||
| EPS | $-4.49 | US—/3,121 Sec—/205 |
| BPS | $3.41 | US#2,435/3,121 Sec#156/205 |
Company Info
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.